title: Establishing a cancer genetics programme in Asia - the singapore experience.
abstract: Cancer genetics is now an established oncology subspecialty with the primary prevention role of identifying high-risk individuals through genetic information for enrolment into screening and preventive programmes. Integrated into major Western centres since the late 1990s, such a programme has been established in Singapore since 2001. Our programme has evaluated 367 index patients comprising mainly breast and colorectal cancer cases. Cancer patients were receptive to genetic counselling, but cost posed a major barrier to genetic testing. However, when the cost barrier was removed through government subsidy plans, more than half of high-risk patients still declined testing. The major barriers were reluctance to involve family members, perception that the information would not change management, and fears of negative feelings. Confirmed mutation carriers were compliant to screening and receptive to prophylactic surgery. Uptake of predictive testing among cancer-free family members has been low, possibly arising from the stigma associated with cancer in our Asian culture. These potential barriers are being addressed through government subsidy plans, continuing education to increase awareness, and being culturally sensitive when dealing with the Asian family.
authors.affiliation: Department of Haematology-Oncology, National University Hospital, Singapore. Soo_Chin_Lee@nuh.com.sg.
authors.forename: Wei-Shieng
authors.initials: WS
authors.lastname: Chieng
authors.forename: Soo-Chin
authors.initials: SC
authors.lastname: Lee